{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:47:33Z","timestamp":1770454053047,"version":"3.49.0"},"reference-count":65,"publisher":"Wiley","issue":"s36","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":4200,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p>The currently available respiratory topical corticosteroids are all effective at reducing the nasal symptoms of itch, sneezing, rhinorrhoea and obstruction associated with allergic rhinitis. The mechanism of action of corticosteroids is related to their anti\u2010innammatory activities. They have been documented to prevent fluid exudation and reduce the number of circulating inflammatory cells, including lymphocytes, mast cells, basophils, eosinophils, macrophages, and neutrophils. This occurs through multiple mechanisms, e.g. eosinophil infiltration is suppressed by preventing cytokine production, reducing local mechanisms of tissue infiltration, and decreasing eosinophil survival. Furthermore, corticosteroids also reduce preformed and newly\u2010generated mediators (e.g. histamine, tryptase, prostanoids, leukotrienes), and inhibit production of cytokines and chemokines by inflammatory cells (e.g. IL\u20101 through IL\u20106, IL\u20108, RANTES, TNF\u2010\u03b1, IFN\u2010\u03b3 and GM\u2010CSF). The currently available corticosteroids differ pharmacologically. Fluticasone propionate appears to have the greatest affinity for the glucocorticoid receptor, and binds more quickly and dissociates more slowly from the receptor compared with other corticosteroids, suggesting a more prolonged duration of action. Its increased specificity for respiratory tissue may lead to greater potency with less potential for systemic adverse effects. Fluticasone propionate has been compared with other corticosteroids in animal models for relative topical and systemic potency, and according to these data. it has the most favourable risk\u2010benefit ratio.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb04820.x","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T22:39:29Z","timestamp":1230763169000},"page":"33-40","source":"Crossref","is-referenced-by-count":45,"title":["The pharmacological basis for the treatment of perennial allergic rhinitis and non\u2010allergic rhinitis with topical corticosteroids"],"prefix":"10.1111","volume":"52","author":[{"given":"E. O.","family":"Meltzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)80678-6"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.3.7545059"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb02724.x"},{"key":"e_1_2_1_5_2","first-page":"110","volume-title":"Anti\u2010inflammatory steroid action: basic and clinical aspects","author":"Cohen JJ.","year":"1989"},{"key":"e_1_2_1_6_2","first-page":"192","article-title":"Topical gluco\u2010corticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin\u20104 in the nasal mucosa in allergen\u2010induced rhinitis","volume":"82","author":"Masuyama K","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_1_7_2","first-page":"193","article-title":"Fluticasone propionate aqueous nasal spray reduces nasal eosinophils and cytokine activity of patients with allergic rhinitis [Abstract]","volume":"95","author":"Alvarado C","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_8_2","first-page":"739","volume-title":"Allergy principles and practice","author":"Schleimer RP.","year":"1988"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4049\/jimmunol.137.1.150","article-title":"Effect of cyclosporin A and dexamethasone on interleukin\u20102 receptor gene expression","volume":"137","author":"Reed JC","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60586-6"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.138.2.532","article-title":"Synthesis and release of leukotriene C4 by human eosinophils","volume":"138","author":"Owen WF","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90182-N"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115524"},{"key":"e_1_2_1_14_2","first-page":"S59","article-title":"Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma","volume":"141","author":"Schleimer RP.","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_15_2","volume-title":"Allergy","author":"Bochner BS"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.37.2.193"},{"key":"e_1_2_1_17_2","first-page":"A804","article-title":"Injection of human subjects with RANTES causes dermal infiltration of eosinophils (EOS) and mononuclear cells (MNC) [Abstract]","volume":"9","author":"Beck L","year":"1995","journal-title":"FASEB J"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4049\/jimmunol.155.1.410","article-title":"Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids","volume":"155","author":"Stellato C","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.12.2694.2694"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00185082"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","article-title":"Glucocorticoids inhibit cytokine\u2010mediated eosinophil survival","volume":"147","author":"Wallen N","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90317-9"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90223-3"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90082-5"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130201"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90005-X"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.10.5.8179909"},{"key":"e_1_2_1_28_2","first-page":"167","article-title":"Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction","volume":"122","author":"Dahl R","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"e_1_2_1_29_2","first-page":"483","volume-title":"The mast cell in health and disease","author":"Schleimer RP","year":"1992"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6636.1572-a"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90198-4"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/287147a0"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706113162403"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/292454a0"},{"key":"e_1_2_1_35_2","first-page":"298","article-title":"Intranasal fluticasone propionate reduces histamine and tryptase in the mucosa of allergic rhinitis patients [Abstract]","volume":"91","author":"Meltzer EO","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)80214-4"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.2.406"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.4049\/jimmunol.139.7.2303","article-title":"Interleukin\u2010l production by human lung tissue. II. Inhibition by anti\u2010inflammatory steroids","volume":"39","author":"Bochner B","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_39_2","first-page":"416","article-title":"Immunoglobulin E\u2010dependent stimulation in human alveolar macrophages: significance in type 1 hypersensitivity","volume":"65","author":"Fuller RW","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_40_2","first-page":"199","volume-title":"Antiinflammatory steroid action","author":"Guyre PM","year":"1991"},{"key":"e_1_2_1_41_2","first-page":"1255","volume-title":"Asthma and rhinitis","author":"Kamada AK","year":"1995"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/278456a0"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(82)91588-1"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.01.040183.002003"},{"key":"e_1_2_1_45_2","first-page":"301","article-title":"IL\u20101 and EN\u2010gamma increase vascular permeability","volume":"64","author":"Martin S","year":"1988","journal-title":"Immunology"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11614.x"},{"key":"e_1_2_1_47_2","first-page":"S39","article-title":"Effect of glucocorticosteroids on microvascular permeability","volume":"141","author":"Williams TJ","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.3.605"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90323-G"},{"key":"e_1_2_1_50_2","first-page":"193","volume-title":"New drugs for asthma","author":"Brattsand R","year":"1992"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503303321307"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(94)90054-X"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.4_Pt_2.S1"},{"key":"e_1_2_1_54_2","first-page":"A212","article-title":"Biologic activities of some corticosteroids used in asthma [Abstract]","volume":"149","author":"English M","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_1_55_2","first-page":"62","article-title":"Development of new glucocorticosteroids with a very high ratio between topical and systemic activities","volume":"122","author":"Brattsand R","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"e_1_2_1_56_2","first-page":"165","article-title":"The efficacy of fluticasone propionate aqueous nasal spray for treatment of rhinitis is dependent on topical application [Abstract]","volume":"93","author":"Hampel F","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_57_2","first-page":"253","article-title":"Nasal priming","volume":"79","author":"Wachs M","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_58_2","first-page":"26","article-title":"In vivo demonstration of inflammatory mediator release following nasal challenge with antigen","volume":"64","author":"Naclerio RM","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90139-X"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb00399.x"},{"key":"e_1_2_1_61_2","first-page":"240","article-title":"Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis","volume":"73","author":"Banov CH","year":"1994","journal-title":"AM Allergy"},{"key":"e_1_2_1_62_2","first-page":"165","article-title":"Fluticasone propionate aqueous nasal spray effectively treats perennial non\u2010allergic rhinitis [Abstract]","volume":"93","author":"Selner J","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80040-9"},{"key":"e_1_2_1_64_2","first-page":"184","article-title":"An assessment of HPA axis effects of fluticasone propionate aqueous nasal spray using 6\u2010hour ACTH infusion [Abstract]","volume":"55","author":"Vargas R","year":"1994","journal-title":"Clin Pharm Ther"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90216-3"},{"key":"e_1_2_1_66_2","first-page":"58","article-title":"Long\u2010term safety study of fluticasone propionate aqueous nasal spray [Abstract]","volume":"74","author":"Li J","year":"1995","journal-title":"Ann Allergy"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb04820.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb04820.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:40:07Z","timestamp":1695768007000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb04820.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":65,"journal-issue":{"issue":"s36","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb04820.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb04820.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}